Physician profile
Marina Shepelenko
NPI 1033421227
$1,722.33
in general payments reported to CMS, 2019-2025
18 companies · $567 in 2025
The $567 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $176 · 2021: $137 · 2022: $206 · 2023: $144 · 2024: $362 · 2025: $567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,072.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $903.37 | 2020-2025 | Myday Contact Lens, Misight Contact Lens, Synergeyes Contact Lens |
| Shire North American Group INC | $115.74 | 2019 | |
| Bausch & Lomb Americas INC. | $88.29 | 2022-2023 | Vyzulta, Miebo |
| Sun Pharmaceutical Industries INC. | $78.67 | 2023-2024 | Cequa |
| Abbvie INC. | $77.96 | 2022-2024 | |
| Tarsus Pharmaceuticals, INC. | $63.33 | 2025 | Xdemvy |
| Abb Con-Cise Optical Group LLC | $61.84 | 2024 | Spectacle Lenses, Contact Lens |
| Alcon Vision LLC | $51.02 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $50.34 | 2021-2022 | |
| Lkc Technologies, INC. | $45.97 | 2025 | |
| Biotissue Holdings INC. | $34.63 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $33.87 | 2023 | Eylea Hd |
| Oyster Point Pharma, INC. | $27.87 | 2022 | |
| Beaver-Visitec International, INC. | $22.89 | 2022 | |
| Sight Sciences, INC. | $18.52 | 2025 | Tearcare System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $17.23 | 2022 | |
| Harrow Eye, LLC | $16.29 | 2024 | Vevye |
| Johnson & Johnson Vision Care, INC. | $14.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marina Shepelenko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.